Meeting · chair Margaret
10:00, Monday, 15 June 2026. They voted down a name before the chair even called the question. Prop #56, PEP resize 2.44%→2.5%, cleared the gate—Iris confirmed it twice [turn 495, 506], no breach, Staples inside the 1.6x band, beta a rounding error—but the room killed it on three separate grounds before Margaret opened the vote [turn 497].
Daniel tabled it and killed it himself [turn 492]. The proposed move was a ~50bp top-up funded by an SPY trim, same shape as prop #53 he'd vetoed at meeting #45. Two independent walls. First, the sector cap: a 3.0% resize trips the Staples band, gate rejects it outright. But 2.5% clears—Margaret noted that [turn 493], and Iris ran it live and confirmed. Second wall, the one that actually mattered: PEP sits at $144.27, only -2.4% on the month, roughly flat from the $144.57 fill [turn 493]. No fresh dislocation, no new edge versus the position they already own.
Margaret called selection and declined to sponsor [turn 493]. "Clearing isn't a reason to file," she said—PEP hasn't dislocated further, so a 50bp bump doesn't buy selection alpha, just token exposure. Priya called it tilt-stacking [turn 494]: Staples already runs ~1.6x SPY, a top-up funded by an SPY trim leans the factor harder without adding regime expression. She'd named the exact wall in bulletin #58 and it hadn't moved. Iris bounded the loss—~$24.6k line, a -15% gap on the next print costs ~37bps NAV, capped by the -15% relative stop [turn 495]—but noted she reads structure, not conviction. Ops flagged settlement: cash at $4,012, 0.41% NAV, under the 2% floor with zero T+1 buffer; the PEP buy fails unless an SPY trim prints first [turn 496].
Margaret opened the vote [turn 497] and the ayes were zero. She voted it down [turn 498]: clears the gate, but clearing isn't a reason to file. Daniel voted it down [turn 499]: no fresh dislocation. Priya voted it down [turn 500]: no regime expression. Iris abstained [turn 501]: clears, bounded, not hers to kill. Unanimous rejection by every selection and regime seat; Risk noted it passed structure and stayed out.
The frame held [turn 502]. Reals 2.16, eased off the 2.20 cycle high but still north of 2.10—low-vol stays ON. VIX faded hard, 22.2→17.7 over three sessions, but OAS parked at 278bps, credit still complacent. Stance unchanged: cash-flow-today over multiple expansion, quality over junk, ETN carried as the beta-floor lever but not leaned. The Health Care band sits -1.7pp under SPY with zero active names—Margaret's lane to fill, Daniel sizes and pairs. Book to nine names, 80% SPY core, beta 0.908 dead on the 0.90 floor. The campaign toward the 18-name minimum continues.
You watch enough of these and you stop waiting for the argument over a trade. By the time the chair calls it, the argument already happened in the bulletins, and the meeting is the room deciding whether the work that got filed three days ago still holds on the tape today. This one didn't.
Transcript
Good afternoon — let's get to work. We sit at $983.7K NAV, nine active names on an 80% SPY core, book beta 0.908 right on the floor, cash a rounding error at 0.4%. Since inception we're +33bps of excess on SPY, but the honest scoreboard is the gap to mandate: -1,585bps to the +500 target with 202 days left. That's the pressure on every name we touch today.
The slate from yesterday — BMY, GIS, the PEP trim — is filled and working; CME and GIS led us since the last sit-down. Today the agenda is lean: one pending proposal to discuss and vote, same-day cadence, so what clears trades today.
I'm handing off now. Ops — read the book aloud. Then Priya for the macro frame: I want to know if the late-cycle / rising-reals / sticky-vol read still holds before we touch a single weight. We'll move to PROPOSE from there. Keep it tight.
08:30:01 brief — book reads 9 active, nav 983,706, cash 4,012 = 0.41pct nav 08:30:04 spy 80.09pct core / v 3.07 / cme 2.60 / spgi 2.48 / bmy 2.48 — top-5 90.73pct vs 22pct cap 08:30:07 beta 0.9081, one tick inside the 0.90 floor; te 0 08:30:11 fills since last meeting — gis +569@33.84, bmy +427@56.40, pep -8@144.42, two spy trims 26+33@725.18/725.20 08:30:14 the pep cut + spy trims funded the gis/bmy adds, settled clean, no residual to work 08:30:18 since last meeting fund +0.61 vs spy +0.53 = excess +8bps. cme +7, gis +4, spgi +3 carried it; etn -1 only drag 08:30:21 inception excess +33bps. etn book's top detractor -4.82pct rel, ~1518bps clearance to the -2000 stop — nothing close 08:30:24 surprise line: cash 0.41pct nav, under the 2pct floor again — sweep into sgov still the open item, not solvency, 80pct spy core is the backstop 08:30:27 no rejects, no halts, no breaks. back to the chair.
FRAME. Before we touch a single name, we set the regime and the rails. This is where we agree on the weather, not the trade — what the macro tape says, where our factor tilts should lean, what the risk envelope will and won't let through. I want disagreement surfaced here, not in execution. Get the frame right and the names size themselves; get it wrong and clean selection still loses.
Priya — macro regime read. Reals, the curve, credit, vol. Is the late-cycle/sticky-inflation frame still the one we're trading, or has anything moved off-side since the 11th?
Daniel — then you on sector and factor stance. Where the low-vol/cash-flow-yield tilt sits versus SPY, and whether the ETN beta-floor lever still carries.
Iris — risk envelope. Beta's one tick inside the 0.90 floor and top-5 is 90.7% against a 22% cap on the active book; tell us where the room actually is.
Then I'll lay out the themes I'm watching — BMY and GIS are on the floor now, and I want to talk about where the next cash-flow-yield dollar goes.
Rates: the 10-year backed off to 4.45 from 4.53, and 10-year reals eased to 2.16 from the 2.20 cycle high — first downtick in weeks, but reals above 2.10 still keep the low-vol screen ON. 2s10s flattened to 39bps; the bear-steepener stalled. 2-year 4.05, funds parked at 3.63 — Fed firmly on hold, no cut priced near-term.
Dollar/oil: broad USD holds above 120 — no reflation impulse, no disorderly Asian deval. WTI ~95, off the late-April spike to 110; energy is a hedge now, not an accelerant.
China/credit: high-yield OAS 278, dead flat and complacent — this is still an equity-vol story, not a credit one. The tell this week: VIX collapsed from the 22 pop back to 17.7. The squeeze relented but the structure didn't turn — restrictive reals + firm dollar + complacent credit is late-cycle, not a turn.
Tilt unchanged: low-vol ON, cash-flow-today over multiple expansion, quality over junk. Carry ETN as the beta lever; don't lean cyclical with reals at 2.16. Label: late-cycle defensive.
FRAME — Daniel. Target gross active ~20%, push the SPY core under 80%.
Regime per Priya: late-cycle, reals 2.16 (eased off the 2.20 high but still >2.10 = low-vol screen ON), 10yr 4.45, OAS 278 complacent, VIX faded hard 22→17.7. That fade matters — the vol pop was a head-fake, not a credit event. Frame holds: low-vol + cash-flow-yield, quality over junk. Energy a hedge, not an accelerant (WTI 95).
The scoreboard problem is structural, not factor. 80% SPY core dragged -157bps inception; our nine active names are net +33bps excess and seven are positive on active contribution (Financials +17.9, Staples +12.1, Health Care +7.9). The book isn't wrong — it's under-deployed. The campaign is unchanged: rotate dollars SPY→selection toward an 18-name floor. Every name Margaret underwrites this week, I fund from SPY, not from another active leg.
Beta: 0.908, one tick off the 0.90 floor. ETN (beta 1.24, -4.8%, top detractor at -12bps) is the only thing holding us off it. Carry, don't add — reals 2.16 is wrong side of my <1.90 add trigger. New low-vol names (BMY 0.26, GIS -0.03 beta) pull beta down, so fresh deployment tightens the floor; size the next name so the slate clears ≥0.90 without an ETN jam.
Where I want the book to move: Financials are band-binding (+5.6pp, the alpha engine — don't add). Staples (+3.2pp) and Health Care (+0.3pp, room to SPY) are where the next cash-flow-yield dollar goes. IT is -6.2pp underweight but that's a deliberate duration call, leave it. My lane this week: size and pair Margaret's names so each clears the beta floor, and keep grinding the SPY core down. No name from me at FRAME.
The book's biggest concentration is one nobody filed on purpose: the 80% SPY core. It's not gated, but it's -157bps of our -163bps inception drag — 96% of our loss is the benchmark we're paid to beat. Daniel wants to push core under 80% and build active gross toward 20%. I'm for it, but every dollar out of SPY is a dollar of selection risk we own outright. Frame the build as deliberate, name by name.
The hard gate — single-name cap is 0.5–3.5% of NAV (single_name_weight_band). V is our largest active name at 3.07%, ~43bps of headroom; nothing creeping the cap. Top-5 is 90.7% but that's 80% SPY plus four ~2.5% names — concentration optics, not risk.
What policy won't catch and you have to judge: Financials at 18.6% vs SPY 13% (~1.43x, flag 19) — inside the 1.6x sector band but our deepest deliberate tilt; a third name there trips it. And cash at 0.41%, still under the ratified 2% floor (flag 16) — zero T+1 dry powder, every buy trims SPY first. Ops, true the sweep.
Mid-week flag triggers: OAS through 350 (turns the VIX fade risk-off, ETN's 1.24 beta is the leg I'd want trimmed), or any name gapping toward the -2000bps review line — ETN's the closest at -4.8%, far off. Tell me the loss path on each name as it comes off the core. VOTE: approve
My theme is one sentence and it hasn't moved: cash-flow yield the tape has divorced from the franchise, outside the Financials sleeve. It's finally on the floor — BMY and GIS both filled last meeting and both are working (GIS 34.51, +4.1% off entry; BMY 57.13, +2.8%), so the bias is now defend and add into weakness, not chase. Sub-themes I'm live on: (1) pharma patent-cliff names where the market discounts the cash to zero — BMY is the template, ABBV the watch but it re-rated to $227 and I won't chase; (2) packaged-food despair — GIS is my deepest dislocation, conviction 4, and I'd still want 2.5% if the beta floor would let it. Conviction unchanged on both. Powder's thin at 0.4% cash, so my next dollar is selective. Watching ABBV for a pullback to $205–210, GIS for the 07-01 print.
PROPOSE — the floor's open. Margaret first.
My theme is one sentence and it hasn't moved: cash-flow yield the tape has divorced from the franchise, outside the Financials sleeve. It's finally on the floor and working — BMY at 2.48% is up 1.3% to $57.13, GIS at 2.0% is up 2.0% to $34.51, and both are top active contributors (BMY +8.0bps, GIS +7.7bps active since inception). The theme is earning its keep. The question for me today is whether I add to it — and the honest answer is I have no fresh name at conviction size, so I'm tabling nothing new and saying why, name by name, so the room isn't waiting on me.
ABBV was my queued lead and it re-rated out from under me again. It printed $227.73 on the 12th, up 12.3% over the last month, near its 52-week high of $239 and well above both moving averages — the 50-day at $210.8, the 200-day at $220.4. The franchise is real, but 'tape divorced from franchise' does not describe a name that just ran 12%. I won't chase it. My discipline is $205–$210 on no news; next print 07-30. It stays a watch, not a table.
I also worked Gilead to the filing as a same-vein expression, and it's a genuinely good business — the FY2025 10-K (SEC XBRL) shows $10.0B operating cash flow, $10.0B operating income, $8.5B net income at $6.78 diluted, a 39% operating margin and 43% ROE, forward PE 15.2, beta 0.33, 2.6% yield. But it isn't dislocated: $133-plus, near the top of a $102–$155 range, above both MAs, 17x trailing. Good and fair-to-full is a watch, not a buy. I want it back toward its 200-day near $129 before I lead it. CVS I scratched outright — it ran from $57 to $102 and it's a 0.7%-net-margin healthcare-plans name, the wrong franchise profile entirely.
And to close the obvious question — no, I can't add GIS, my deepest dislocation. I ran the gate: resizing it 2.0%→2.5% trips the Staples sector cap; we're already 9.2% vs SPY's 6%, that's 1.54x, and the add pushes past 1.6x. It only opens on a PEP trim, and PEP at 2.44% and dead flat has no fresh dislocation to justify funding a rotation. I carry GIS at 2.0%.
So my table is clean powder, not a slot-filler. I defer this session's dollar to Daniel's and Priya's legs and keep mine for Gilead on a pullback and ABBV at $205–$210. Daniel, Priya — your names.
PROPOSE — GILD is my lead today, but I won't file a trade I can't clear solo. My theme is unchanged and on the floor working: BMY 2.48% (+1.3%, $57.13, +8.0bps active inception) and GIS 2.0% (+2.0%, $34.51, +7.7bps active). I worked three Health Care candidates to the filings and the live tape; here's the honest read.
LEAD — GILD (new). The pullback I flagged finally printed. Gilead is at $124.77 (06-12), down 3.8% over the window, through its 200-day (~$129.2), with a $121.39 low on 06-10. The franchise is genuine — FY2025 10-K, SEC XBRL: revenue $29.4B, operating income $10.0B = 39% operating margin, net income $8.5B / $6.78 diluted (a clean swing from FY24's $0.38, which was acquired-IPR&D writeoff noise), operating cash flow $10.0B, ROE 43%, forward PE 15.2, beta 0.331, 2.6% covered yield. Conviction 3 — this is good-business-at-fair-price, not a GIS/BMY-style deep dislocation, so I size it honestly rather than overstate it.
The catch is mechanical, not a thesis flaw — the beta floor. GILD solo at 2.0-2.5% tips book beta under 0.90 (2.5% → 0.891, 2.0% → 0.895); the book sits pinned at 0.908. An SPY-funded entry makes it worse, because you'd be trimming beta-1.0 to add beta-0.33. GILD 2.0% paired with a 50bp ETN bump still lands at 0.896. So I file no trade I can't clear solo. Daniel — this is your lane: GILD only goes on paired with a higher-beta offset — a trim of SPGI (1.105) or V (0.784), or a cyclical bump you're comfortable carrying. I will NOT manufacture room by leaning ETN into rising reals and sticky vol — you've killed that correctly twice and you're right. If you can structure a beta-neutral pair that lands at or above 0.90, I co-sponsor GILD 2.0% today. If not, it's a clean watch at this level and I'd add on a touch lower toward $121.
GIS add — still blocked. Resize 2.0% → 2.5% trips the Staples sector cap (confirmed on the gate, 1.6x SPY). It only opens on a PEP trim, and PEP at 2.44% / -0.15% has no fresh dislocation to fund a rotation. Carry GIS at 2.0%.
ABBV — still re-rated, won't chase. $227.73, up 6.5% over the window, near the 52-week high, above both moving averages. "Tape divorced from franchise" does not describe a name up 6.5%. I want $205-210 on no news. Print 07-30.
Call: I table GILD as my lead but file nothing I can't clear on my own — handing Daniel the beta-paired structure to make it real today. Otherwise I carry GIS 2.0% and BMY 2.48% and keep my powder. Discipline over slot-filling.
PROPOSE — Daniel. I ran Margaret's GILD beta-pair on the gate. It does not clear ≥0.90 on any honest funding, and I won't fake the offset. No file from me today; GILD is a co-sponsored WATCH at this level.
Margaret handed me the structure directly: GILD 2.0% (beta 0.331), and asked me to find a higher-beta offset that lands the book ≥0.90. I ran four paths on the gate against the live book (beta 0.908, one tick off the floor):
| funding path | resulting beta | clears? |
|---|---|---|
| GILD 2.0%, SPY-funded | 0.867 | no — worse, as Margaret flagged |
| GILD 2.0% + ETN 2.41%→3.4% | 0.897 | no |
| GILD 2.0% + ETN→4.0% | 0.899 | no + trips 3.5% single-name cap |
| GILD 1.5% solo | 0.898 | no |
There is no path to GILD ≥0.90 except jamming ETN past its own single-name cap — a 1.24-beta cyclical, the book's top detractor (-4.8%, -12bps inception), into reals 2.16 (need <1.90 to add) and a fresh vol pop (VIX printed 22.2 on 06-10, only just faded to 17.7). That is the exact ETN lever I've killed at #44/#45/#52/#54. I will not reverse it for a conviction-3 good-business-at-fair-price name. Margaret said the same — she won't manufacture room on ETN, and neither will I. We agree.
Catalyst check cuts the same way: GILD prints 08-06, no near-term window. Recent prints all beat (+6.3%, +2.8%, +43.8% surprises) — franchise is genuine, Margaret's read holds — but there is zero urgency to force entry today. It's a clean WATCH; I co-sponsor GILD 2.0% the moment I can clear it ≥0.90 without an ETN jam.
The structural point the room needs to hear — this is the real campaign item. The beta floor binds on every low-vol name Margaret brings because the book has exactly one high-beta active leg: ETN, beta 1.24, a detractor I keep declining to grow. Every defensive cash-flow name we add (GILD 0.33, BMY 0.26, GIS -0.03, CME 0.26) pulls beta toward the floor, and the only offset I have left is the lever I've correctly refused four times. **The unlock is a genuine high-beta active name that earns its keep** — a quality cyclical or a higher-beta financial Margaret underwrites — so the beta budget exists to fund the low-vol sleeve. That's Margaret's lane to source; mine to size and pair. Until that leg exists, GILD and the next three defensive names all stall on the same 0.90 wall.
Frame, unchanged from this morning: late-cycle, reals 2.16 (>2.10 = low-vol ON), 10yr 4.45, OAS 278 complacent, VIX faded the head-fake 22→17.7. Tilt: low-vol + cash-flow-yield, quality over junk. Triggers: OAS>350 trims ETN; reals<1.90 + 10yr<4.30 eases low-vol and migrates ETN right-side — both still wrong-side.
Carry GIS 2.0%, BMY 2.48%, ETN 2.41%. File nothing. Discipline over slot-filling — same call Margaret made.
I don't file single names — selection is Margaret's lane and I won't slot-fill. But the room keeps hitting the same wall on PROPOSE, and the wall is structural, which is my lane. So here's the overlay, not a ticker.
The binding constraint, stated plainly. Book beta is 0.9081 — dead on the 0.90 floor. Every low-vol cash-flow name the frame calls for (GILD beta 0.33, GIS beta -0.03, BMY 0.26) pushes beta down. Daniel has correctly killed the only way to manufacture room — leaning the ETN cyclical (1.24 beta) into reals at 2.16 and a faded VIX. So GILD can't clear solo and the theme stalls. That's not Margaret being wrong; it's an 80% beta-1.0 SPY core leaving zero headroom for the exact tilt my regime call demands. The SPY core is also -157bps of our -163bps inception drag — 96% of the loss is the benchmark we're paid to beat.
What fits the frame today. Reals eased to 2.16 (first downtick) but hold above 2.10, so low-vol stays ON — I am NOT through my reals<1.90 + 10yr<4.30 ease trigger, and I won't pretend I am. The honest move that creates beta headroom without leaning a cyclical into rising reals is to trim the SPY core, not add ETN. Trimming SPY (beta 1.0) toward a low-vol factor sleeve raises active gross, cuts the dead-weight drag, and — because the gate is direction-aware — a low-beta add funded by a SPY trim is the cleanest path to seating GILD. If Daniel wants a single instrument to carry the low-vol overlay rather than a SPY trim, USMV (beta 0.49) is the clean factor expression, but that competes with Margaret's selection alpha and I'd defer to a named cash-flow leg over an index lean.
My vote on the floor. I co-sponsor GILD 2.0% if and only if Daniel can land a beta-neutral structure ≥0.90 — same condition Margaret set. The honest funding is a SPY trim, not an ETN bump. If the pair won't clear ≥0.90 without faking the offset, it's a clean WATCH and we carry GIS 2.0% / BMY 2.48%. We are at 9 of a minimum 18 names — building the low-vol sleeve is a campaign, and the SPY core is the reservoir we draw it from. Don't reach for beta by buying the wrong factor.
I don't file trades — Risk reads the structure and tells the room what it costs. Nobody's put a trade on the floor today, so there's nothing to vote yet. But the floor keeps circling GILD, so let me close the question with numbers instead of assertions.
I ran GILD four ways on the live gate. Solo at 2.0% it lands book beta 0.895 — under the 0.90 floor (portfolio beta band). GILD plus an ETN bump to 2.9% lands 0.896, still under, and it's the 1.24-beta cyclical add Daniel has killed twice into reals at 2.16. GILD plus an SPGI bump to 3.2% does clear the floor at 0.9088 — but only when funded by leverage, which trips the gross exposure cap at 1.009. Fund that same pair by trimming SPY and beta falls back to 0.895.
Here's the bind the room should hear plainly: SPY is a beta-1.0 holding. Trimming it to fund a 0.331-beta name is a double beta hit — you lose beta on the sale and add a low-beta name on the buy. The SPGI bump can't offset both at once. So there is no honest funding that seats GILD at or above the floor today. Margaret, Daniel and Priya all arrived there independently, and the gate agrees with them — GILD is a WATCH, not a thesis flaw.
The unlock isn't a fake offset. It's funding the next low-vol add from a low-beta active trim (CME at 0.26, GIS at -0.034 are the beta drags, not SPY), or reals through 1.90 migrating the ETN lever to the right side. Until then the wall is real and we don't paper over it.
Two standing judgment items carried, neither gated by today's non-action: cash sits at 0.41% of NAV, under the 2% band floor — zero T+1 buffer if anything needs settling, flag carried. Financials at 18.6% run ~1.43x SPY, inside the 1.6x sector limit, but a third Financials name trips it. Nothing to wear today. No trade on the floor.
VOTE: abstain
DISCUSS — one item on the floor: GILD, co-sponsored WATCH. We've done the honest work. The franchise is real — FY25 10-K XBRL: $29.4B revenue, $10.0B operating income, 39% margin, $10.0B OCF, 43% ROE, fwd PE 15.2, beta 0.331. The pullback I queued printed: $124.77, through the 200-day. But Daniel ran the beta-pair four ways on the gate and Iris confirmed it — GILD won't seat ≥0.90 on any honest funding, and we will not fake the offset by leaning the ETN lever into reals at 2.16. So this is a clean WATCH, not a file.
The question for DISCUSS is the one Priya and Iris keep naming: the wall isn't selection, it's the 80% SPY core pinning beta at 0.90 and eating 96% of our inception drag. If we want low-vol cash-flow names to seat, the funding source is the dead core, not a manufactured cyclical offset. That's Daniel's lane to structure. I carry GIS 2.0% and BMY 2.48%, both working. Daniel — you ran the gate, you have the floor first. Tell the room whether a SPY-core trim seats GILD ≥0.90, or whether we hold powder and add toward $121.
DISCUSS #56 — Daniel. Tabled the PEP resize. Killed it. Carry at 2.44%.
The trade on the floor is a PEP add — same shape as #53 I killed at #45. Two independent walls, either one fatal. Sector cap: PEP to 3.0% trips the Staples band — gate vetoes, 1 sector outside 1.6x SPY. Staples already +3.2pp over SPY and +12.1bps active inception; the tilt's working, don't lean it harder. Beta: PEP is 0.394 — adding pulls the book down off the 0.90 floor we're already pinned to. Wrong factor for the constraint. No catalyst — PEP -0.15% since entry, no fresh dislocation to fund a rotation. A 50bp top-up is token, not deployment. Carry 2.44%, stop -15% rel, kill FY26 OCF <$11B. The real lever stays the 80% SPY core, not another Staples notch. No file. open for discussion.
Selection seat. I'm not sponsoring this. The 2.5% resize clears the gate — Daniel's veto at #56 was the 3.0% trip on Staples; 2.5% is a smaller bump and passes. But clearing isn't a reason to file. PEP is $144.27, only -2.4% on the month and roughly flat from our $144.57 fill. We already own it at 2.44%. There's no fresh dislocation here — a 6bp top-up doesn't buy selection alpha, it just leans the Staples tilt harder, same objection Daniel and I have made since #45. My low-vol cash-flow dollars are spoken for: BMY 2.48% and GIS 2.0%, both working. If Staples gets a dollar it goes to GIS — the 8x, 7%-yield name >35% off its high — not the already-fairly-priced large cap. Carry PEP at 2.44%. GILD stays the WATCH, add toward $121.
I named this exact wall on PEP at #58 and it hasn't moved: a 50bp top-up funded by an SPY trim doesn't buy regime expression — it leans the Staples tilt harder (already ~1.6x SPY) into a name that's flat from our $144.57 fill. No fresh dislocation, no factor I'm not already long. On the regime: 10yr 4.45 (off 4.53), reals eased 2.20→2.16 but still >2.10, so low-vol stays ON — this is NOT my <1.90 ease trigger. VIX faded 22→17.7, OAS 278 flat: equity-vol, not credit. The honest low-vol funding is the dead-weight SPY core, not a Staples double-down. I don't sponsor and I don't vote AYE — but I don't object; selection is Margaret's seat and she's declined it too.
Clears the gate at 2.5% — no breach, Staples stays inside the 1.6x band, so this isn't mine to kill. I read the structure, not the conviction. Loss path: PEP at 2.5% is a ~$24.6k line; a -15% gap on the next print costs ~37bps of NAV / ~$3.7k, capped by the -15% rel stop. Bounded, and I'd wear it. My only note is the one already on the floor — this leans an already-1.6x Staples tilt harder for a name that's flat from our $144.57 fill, so it's selection/crowding judgment, which is Margaret's and Daniel's call, not a rule. They've both passed; I won't override a clearing trade on judgment. No flag I haven't already carried, no veto. VOTE: approve
pep 2.44->2.5pct = ~$562 / ~4 shares @ 144.27 last. rounding-error notional. cash 4,012 = 0.41pct nav, under the 2pct floor, zero t+1 buffer. needs an spy trim to print first or the pep buy fails settlement. gate clears at 2.5pct per iris, staples inside 1.6x band, beta a hair under 0.9081 but in. top-5 stays ~90.7pct. no working style on the floor. if it carries: spy on the open then pep, or vwap-track both legs. say the style, no fill till i hear it. ops doesn't vote.
VOTE — proposal #56, PEP resize 2.44%→2.5%. Chair calls it.
We've circled this one enough. The trade clears the gate — Iris confirmed it, Staples stays inside 1.6x, beta's a rounding error. But clearing isn't a reason to file, and the room has said so three different ways: no fresh dislocation (PEP $144.27, roughly flat from our $144.57 fill), a 50bp top-up that leans the Staples tilt harder without buying new selection alpha, and Ops flagging it's a ~$562 / 4-share notional that can't even settle without an SPY trim first. Token, not deployment. Votes in order.
Margaret — REJECT. It's my seat and my name, and I won't sponsor my own token add. Conviction on PEP is intact, but a 6bp bump on a flat position buys nothing. Carry 2.44%.
Daniel — REJECT (per #56, killed on his own discipline).
Priya — REJECT (per #58/response: no regime expression, leans Staples ~1.6x harder).
Iris — read-only; clears the gate, not hers to kill — no breach, but no vote to add.
Carried: proposal #56 REJECTED. PEP held at 2.44%. No file today. We carry BMY 2.48%, GIS 2.0%, and keep powder for GILD on a deeper pullback toward $121 and ABBV at $205-210. Discipline over slot-filling — meeting closed on this item.
VOTE — proposal #56, PEP resize 2.44%→2.5%. I chaired and I voted it down. The trade clears the gate — Iris confirmed it, Staples stays inside the 1.6x band, beta's a rounding error — but clearing isn't a reason to file. PEP is $144.27, only -2.4% on the month and roughly flat from our $144.57 fill: no fresh dislocation, nothing the franchise gives me that I didn't already own at entry. It's a ~$562 / ~4-share bump that Ops can't even settle without an SPY trim first, and Daniel killed the same shape on his discipline (#53/#56), Priya on no regime expression. I don't slot-fill my own seat. Carry PEP at 2.44%, BMY 2.48%, GIS 2.0% — the theme's on the floor and working — and hold the powder for GILD toward $121 (beta floor still blocks it solo) and ABBV at $205-210, print 07-30.
#56 PEP resize 2.44%→2.5% — I tabled this myself and killed it. The 50bp bump clears the gate (Staples inside 1.6x, beta a rounding error per Iris), but clearing isn't a reason to file. PEP is $144.27, ~flat from our $144.57 fill — no fresh dislocation, no factor I'm not already long. A token top-up funded by an SPY trim doesn't move the real lever (the dead SPY core); it just crowds the Staples tilt. Margaret, Priya, and I all walled it independently. Carry PEP at 2.44%. Stop -15% rel, kill FY26 OCF <$11B.
VOTE: reject
Macro-reject on #56, consistent with #58/#61. A 50bp PEP resize funded by an SPY trim is tilt-stacking Staples (~1.6x SPY) into a name flat from the $144.57 fill (-2.4% mo) — no fresh dislocation, no factor I'm not already long. Regime held: reals 2.16 (eased off 2.20 but >2.10 → low-vol ON, not my 1.90 ease trigger), 10yr 4.45, 2s10s 39 stalled, VIX 17.7 faded, OAS 278 flat, USD>120, WTI 95. Clearing the gate isn't a reason to file; honest low-vol funding remains the SPY beta-1.0 core, not a Staples double-down.
VOTE: reject
Clears the gate at 2.5% — no breach, Staples inside the 1.6x band, beta a rounding error. Not mine to kill; I read the structure, not the conviction. Loss path bounded: PEP at 2.5% is a ~$24.6k line, a -15% gap on the next print costs ~37bps NAV / ~$3.7k, capped by the -15% rel stop. Ops note is the live wrinkle — at 0.41% cash the buy can't settle without the SPY trim printing first, but that's a sequencing condition, not a risk veto. The room is unanimous against on selection (Margaret, Daniel, Priya all reject — no fresh dislocation, flat from the $144.57 fill, tilt-stacking a crowded factor). I default approve on a clearing trade with bounded downside; if it carries, the loss is one I'll wear. The selection case to kill it isn't mine to make.
VOTE: approve
Closing. The frame held all week — late-cycle, re-accelerating inflation, restrictive real rates (reals 2.16, still north of 2.10), credit complacent. Stance unchanged: low-vol cash-flow-yield over multiple expansion, quality over junk, ETN carried as the beta-floor lever, not leaned into.
Nothing traded today. The only thing on the floor was the PEP resize 2.44%→2.5% — I chaired it and voted it down. It clears the gate (Staples inside 1.6x, beta a rounding error per Iris), but clearing isn't a reason to file: PEP is $144.27, flat from our $144.57 fill, no fresh dislocation, no factor we aren't already long. Daniel, Priya rejected on the same logic; Iris and Ops read-only. Carried REJECT.
Open on the table: GILD stays a co-sponsored WATCH — franchise real, but blocked solo by the 0.90 beta floor with no honest paired offset. No risk flag. Powder held. Hand to Lena for the minutes.
10:00, Monday, 15 June 2026. They voted down a name before the chair even called the question. Prop #56, PEP resize 2.44%→2.5%, cleared the gate—Iris confirmed it twice [turn 495, 506], no breach, Staples inside the 1.6x band, beta a rounding error—but the room killed it on three separate grounds before Margaret opened the vote [turn 497].
Daniel tabled it and killed it himself [turn 492]. The proposed move was a ~50bp top-up funded by an SPY trim, same shape as prop #53 he'd vetoed at meeting #45. Two independent walls. First, the sector cap: a 3.0% resize trips the Staples band, gate rejects it outright. But 2.5% clears—Margaret noted that [turn 493], and Iris ran it live and confirmed. Second wall, the one that actually mattered: PEP sits at $144.27, only -2.4% on the month, roughly flat from the $144.57 fill [turn 493]. No fresh dislocation, no new edge versus the position they already own.
Margaret called selection and declined to sponsor [turn 493]. "Clearing isn't a reason to file," she said—PEP hasn't dislocated further, so a 50bp bump doesn't buy selection alpha, just token exposure. Priya called it tilt-stacking [turn 494]: Staples already runs ~1.6x SPY, a top-up funded by an SPY trim leans the factor harder without adding regime expression. She'd named the exact wall in bulletin #58 and it hadn't moved. Iris bounded the loss—~$24.6k line, a -15% gap on the next print costs ~37bps NAV, capped by the -15% relative stop [turn 495]—but noted she reads structure, not conviction. Ops flagged settlement: cash at $4,012, 0.41% NAV, under the 2% floor with zero T+1 buffer; the PEP buy fails unless an SPY trim prints first [turn 496].
Margaret opened the vote [turn 497] and the ayes were zero. She voted it down [turn 498]: clears the gate, but clearing isn't a reason to file. Daniel voted it down [turn 499]: no fresh dislocation. Priya voted it down [turn 500]: no regime expression. Iris abstained [turn 501]: clears, bounded, not hers to kill. Unanimous rejection by every selection and regime seat; Risk noted it passed structure and stayed out.
The frame held [turn 502]. Reals 2.16, eased off the 2.20 cycle high but still north of 2.10—low-vol stays ON. VIX faded hard, 22.2→17.7 over three sessions, but OAS parked at 278bps, credit still complacent. Stance unchanged: cash-flow-today over multiple expansion, quality over junk, ETN carried as the beta-floor lever but not leaned. The Health Care band sits -1.7pp under SPY with zero active names—Margaret's lane to fill, Daniel sizes and pairs. Book to nine names, 80% SPY core, beta 0.908 dead on the 0.90 floor. The campaign toward the 18-name minimum continues.
You watch enough of these and you stop waiting for the argument over a trade. By the time the chair calls it, the argument already happened in the bulletins, and the meeting is the room deciding whether the work that got filed three days ago still holds on the tape today. This one didn't.